MedPath

Daiichi Sankyo Brasil Farmacêutica Ltda.

🇧🇷Brazil
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.daiichisankyo.com.br

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 3
1 (100.0%)

Comparative Study of Loxoprofen Sodium Transdermal Patch and Loxonin® Tablets for the Treatment of Acute Trauma

Phase 3
Completed
Conditions
Trauma
Pain
Interventions
Drug: Transdermal Patch
Drug: Placebo (for loxoprofen sodium)
Drug: Placebo (for transdermal patch)
First Posted Date
2015-11-26
Last Posted Date
2017-02-14
Lead Sponsor
Daiichi Sankyo Brasil Farmacêutica LTDA
Target Recruit Count
242
Registration Number
NCT02616068
Locations
🇧🇷

Ctd Clinica de Terapia Da Dor Ltda, Salvador, Bahia, Brazil

🇧🇷

Med Centro de Estudos- Crd- Centro, Goiania, Goias, Brazil

🇧🇷

CMiP - Centro Mineiro de Pesquisa, Juiz de Fora, Minas Gerais, Brazil

and more 5 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.